University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine: Department of Neuroscience

Puran S. Bora, Ph.D.

Title
Professor, Department of Ophthalmology

Ph.D.
Kumaun University,Nainital/All India Institute of Medical Sciences(AIIMS)
New Delhi, India, Ph.D., Zoology/Biochemistry

Post Doctoral Training
Washington University School of Medicine, St. Louis, MO

Email: PBora@uams.edu

Research Interests

Age Related Macular Degeneration (AMD), an eye disease which can cause loss of central vision in the population over the age of 55 years. Our laboratory is studying the Molecular and Biochemical mechanisms of AMD in order to find a cure and/or prevention of the disease. We have shown the role of complement system in choroidal neovascularization (CNV). CNV is also called wet type AMD. We have shown for the first time, the mechanistic role of complement proteins which will help us to develop an alternative therapy for AMD. In addition to complement therapy we have several inhibitors of AMD which are currently being tested in our laboratory for their role as potential inhibitors of CNV or wet AMD. Our laboratory is also studying the mechanism of action of alcoholism in diabetic retinopathy (DR). The role of alcohol abuse in AMD and DR is not known. We have made some interesting advancement in this area. My laboratory also collaborates with Dr. Nalini Bora‘s laboratory on AMD, Uveitis (eye disease), inflammation of the eye, and related projects.

Selected Publications

  • Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem. 2011;286(23):20991-1001. doi: 10.1074/jbc.M111.226266. PubMed PMID: 21515678; PubMed Central PMCID: PMCPMCID: PMC3121483.
  • Lyzogubov V, Wu X, Jha P, Tytarenko R, Triebwasser M, Kolar G, et al. Complement regulatory protein CD46 protects against choroidal neovascularization in mice. Am J Pathol. 2014;184(9):2537-48. doi: 10.1016/j.ajpath.2014.06.001. PubMed PMID: 25019227; PubMed Central PMCID: PMCPMCID: PMC4188132.
  • Lyzogubov VV, Bora NS, Tytarenko RG, Bora PS. Polyethylene glycol induced mouse model of retinal degeneration. Exp Eye Res. 2014;127:143-52. doi: 10.1016/j.exer.2014.07.021. PubMed PMID: 25088354.
  • Lyzogubov VV, Tytarenko RG, Juan L, NS Bora and PS Bora. Polyethylene Glycol (Peg) Induced Mouse Model Of Choroidal Neovascularization. Journal Biological Sciences, 2011; 286(18) :16229-16237.
  • Bora, N.S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C.L., Morgan, B.P. and Bora, P.S. CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in Wet-type Age-related Macular Degeneration. Journal of Immunology, 2007;178:1783-1790.
  • Valeriy Lyzogubov, Michael Dasso, Nalini Bora, Puran S. Bora,
    Role of thalidomide, senicapoc, and sodium butyrate in choroidal neovascularization: Biochem Biophys Res Commun. 2020; 17; 530(2):367-373. DOI: 10.1016/j.bbrc.2020.07.140
  • Sohn, J.H., Bora, P.S., Suk, J.H., Molina H., Kaplan H.J. and Bora, N.S.: Tolerance is dependent on complement fragment iC3b binding to antigenpresenting cells. Nature Medicine, 9 : 206-212, 2003
  • Bora, P.S., Hu, Z., Tezel, T.H., Sohn, J.H., Kang, S.G., Cruz J.M.C., Bora, N.S, Garen, A and Kaplan, H.J.: Immunotherapy for choroidal eovascularization in a laser induced mouse model simulating exudative (wet) macular degeneration. Proc. Natl. Acad. of Sci. USA., 100: 2679-2684, 2003.
  • Bora, N.S., Sohn, J.H., Bora, P.S. ., Suk, J.H and Kaplan, H.J.: Experimental autoimmune anterior Uveitis is a collagen vascular disease type I collagen is the auto-antigen. J. Immunol. 172: 7086-7094, 2004.
  • Bora, P.S., Sohn, J.H., Cruz, J.C., Nishihori, H, Jha, P, Wang, Y., Kaplan, H.J. and Bora N.S.: Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization. J. Immunology. 174: 491-497, 2005.
  • Jha, P., Sohn, J.H., Qin, X., Nishihori, H., Wang, Y, Kaplan, H.J, Nishihori, S, Manickam, B., Bora, P.S. and Bora, N.S. Complement system plays a critical role in the development of experimental autoimmune anterior uveitis (EAAU). Invest Ophthalmol Vis Sci,; 47:1030-1038, 2006.
  • Bora, P.S., Bora, P.S., Kaliappan, S., Xu, Q., Kumar, S., Wang, Y., Kaplan, H.J. and Bora, N.S. Alcohol linked to enhanced angiogenesis in rat model of choroidal Neovascularization. FEBS Journal (European J of Biochem), 273: 1403-1414. 2006.
  • Jha, P., Sohn, J.H., Qin X, Wang, Y., Kaplan, H.J., Bora P.S., and Bora, N.S.. Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU). J of Immunology, 176: 7221-7231, 2006.
  • Bora, N.S., Kaliappan, S., Jha, P., Qin, X. Sohn, J. H., Dhaulakhandi, D.B., Kaplan H.J. and Bora, P.S. Complement Activation via Alternative Pathway is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H. J of Immunology, 177: 1872-1878, 2006
  • Jha, P., Bora, P.S., Sohn, J.H., Kaplan, H.J and Bora, N.S.Complement system the eye (Review article). Advances in Experimental Medicine and Biology, 586: 53-62, 2006.
  • Bora, N.S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C.L., Morgan, B.P. and Bora, P.S. CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in Wet-type Age-related Macular Degeneration. Journal of Immunology, 2006 (In Press).
  • Sohn, J.H., Bora, P.S., Jha, P., Kaplan, H.J. and Bora, N.S.:”Immunosuppressive Intraocular Microenvironments: Complement, Innate Immunity and Ocular Disease” Niederkorn JY, Kaplan HJ (eds): Chem Immunol, Allergy, Basel, Karger, vol 92, pp 105 – 114, 2007.